Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Intellia Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 304
- −12 vs. Q3 2022
- Shares held
- 78.0M
- +10.0M (+14.7%) vs. Q3 2022
- Total value
- $2.72B
- −$1.08B (−28.5%) vs. Q3 2022
- New holders
- 48
- 120 more added
- Sold out
- 60
- 81 more reduced
5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 7,255,246 | $253.1M | 0.01% | +1,127,106+18.4% | Added |
| Vanguard Group Inc | 7,810,226 | $272.5M | 0.01% | +1,192,903+18.0% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 9,420,782 | $328.7M | 2.85% | −236,270−2.4% | Reduced |
| Pathstone Family Office, LLC | 5,814 | – | – | −42−0.7% | Reduced |
| Ellevest, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −344,868−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −160,356−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Shelton Capital Management | 0 | $0 | 0.00% | −66,500−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −56,513−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −41,521−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −38,287−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −32,140−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −30,478−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −26,551−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −21,970−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −20,119−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,610−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −17,892−100.0% | Sold out |
| L & S Advisors Inc | 0 | $0 | 0.00% | −17,812−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −12,691−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −9,236−100.0% | Sold out |
| Goldstream Capital Management Ltd | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −8,130−100.0% | Sold out |
| Interchange Capital Partners, LLC | 0 | $0 | 0.00% | −7,890−100.0% | Sold out |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −6,600−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −6,546−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −6,510−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −5,048−100.0% | Sold out |
| Pictet & Cie (Europe) SA | 0 | $0 | 0.00% | −5,039−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −4,922−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −4,712−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −4,725−100.0% | Sold out |
| HB Wealth Management, LLC | 0 | $0 | 0.00% | −4,679−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −4,591−100.0% | Sold out |
| Spectrum Planning & Advisory Services Inc. | 0 | $0 | 0.00% | −4,503−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −4,406−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −4,345−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −4,324−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −4,250−100.0% | Sold out |
| Buckley Wealth Management, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −3,703−100.0% | Sold out |
| Orcam Financial Group | 0 | $0 | 0.00% | −3,650−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −3,452−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −3,350−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,428−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,097−100.0% | Sold out |
| Stonehage Fleming Financial Services Holdings Ltd | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Maryland Capital Advisors Inc. | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Benjamin F. Edwards & Company, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Hoey Investments, Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Stapp Wealth Management, PLLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Castle Wealth Management LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Hudock, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Eaton Vance Management | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |